International Biotechnology Trust’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $332K | Hold |
19,900
| – | – | 0.11% | 64 |
|
|
2023
Q2 | $549K | Buy |
+19,900
| New | +$549K | 0.17% | 55 |
|
|
2022
Q3 | – | Sell |
-128
| Closed | -$16.2K | – | 78 |
|
|
2022
Q2 | $16.2K | Buy |
+128
| New | +$16.2K | 0.17% | 69 |
|
|
2021
Q3 | – | Sell |
-152,000
| Closed | -$6.81M | – | 73 |
|
|
2021
Q2 | $6.81M | Hold |
152,000
| – | – | 1.8% | 18 |
|
|
2021
Q1 | $3.94M | Hold |
152,000
| – | – | 1.04% | 25 |
|
|
2020
Q4 | $3.06M | Hold |
152,000
| – | – | 0.84% | 25 |
|
|
2020
Q3 | $2.97M | Buy |
+152,000
| New | +$2.97M | 0.96% | 25 |
|